NG2 is expressed by many tumor types, including glioblastoma multiform (GBM) and melanoma (Chekenya et al., 2008; Prestegarden et al., 2010; Al-Mayhani et al., 2011), and is thus considered a potential therapeutic target in cancer. The gene discussed is CSPG4; the disease is cancer.